Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-061540

Chief Financial Officer gave up 356 shares (to pay taxes)

  • Chief Financial Officer acquired 1,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ruffo Frank Chief Financial Officer 2019-12-18 Option exercise +1,250 167,156 D: show line 1 in the form
Ruffo Frank Chief Financial Officer 2019-12-18 Shares withheld for taxes −356 $1.81 $644 166,800 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ruffo Frank Chief Financial Officer 2019-12-18 Option exercise · Restricted Stock Units −1,250 0 D: show line 3 in the form
Loading xslF345X03/doc4.xml…